![David Piacquad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Piacquad
Director/Board Member at
NEUMORA THERAPEUTICS, INC.
Net worth: 37 185 $ as of 2026-05-30
Profile
David A. Piacquad is currently an Independent Director at Angitia Biopharmaceuticals Guangzhou Ltd. and an Independent Director at Neumora Therapeutics, Inc. since 2023.
Former positions include Senior VP-Business Development & Licensing at Schering-Plough Corp.
from 2006 to 2009, Vice President-Licensing & Acquisitions at McNeil Consumer & Specialty Pharmaceuticals, Inc., Vice President-Ventures & Business Development at Johnson & Johnson, Inc., Principal at Mr. Piacquad Consulting LLC in 2010, and Senior Vice President-Business Development at Amgen, Inc. from 2014 to 2022.
Education includes an undergraduate degree from Colgate University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-26 | 20,100 ( 0.01% ) | 37 185 $ | 2026-05-30 |
David Piacquad active positions
| Companies | Position | Start |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Director/Board Member | 2023-08-31 |
Angitia Biopharmaceuticals Guangzhou Ltd.
 Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Director/Board Member | - |
Former positions of David Piacquad
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 2022-01-31 |
David A. Piacquad Consulting LLC | Corporate Officer/Principal | 2010-05-31 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 2009-11-30 |
Johnson & Johnson, Inc.
 Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Operates as an independent wholesale insurance brokerage company | Corporate Officer/Principal | - |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
 McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Corporate Officer/Principal | - |
Training of David Piacquad
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Health Technology |
Johnson & Johnson, Inc.
Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Operates as an independent wholesale insurance brokerage company | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David A. Piacquad Consulting LLC | |
Angitia Biopharmaceuticals Guangzhou Ltd.
Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
- Stock Market
- Insiders
- David Piacquad
